ETOPOSIDE (VP-16-213) IN MALIGNANT BRAIN-TUMORS - A PHASE-II STUDY

被引：89

作者：

TIRELLI, U

DINCALCI, M

CANETTA, R

TUMOLO, S

FRANCHIN, G

VERONESI, A

GALLIGIONI, E

TROVO, MG

ROSSI, C

GRIGOLETTO, E

机构：

[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

[2] BRISTOL MYERS CO,DIV PHARMACEUT RES & DEV,NEW YORK,NY

来源：

关键词：

D O I：

10.1200/JCO.1984.2.5.432

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：432 / 437

页数：6

共 29 条

[1] CAVALLI F, 1982, CANCER CHEMOTH PHARM, V7, P81
[2] COLOMBO T, 1982, CANCER CHEMOTH PHARM, V7, P127
[3] CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P227
[4] CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P221
[5] CREAVEN PJ, 1982, CANCER CHEMOTH PHARM, V7, P133
[6] DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141
[7] COMBINATION CHEMOTHERAPY WITH 4' DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE), VP-16-213 (NSC-141540) IN L1210 LEUKEMIA
DOMBERNOWSKY, P
NISSEN, NI
[J]. EUROPEAN JOURNAL OF CANCER, 1976, 12 (03) : 181 - 188
[8] DREWINKO B, 1979, CANCER TREAT REP, V63, P373
[9] PHASE-II STUDIES OF DIANHYDROGALACTITOL-BASED COMBINATION CHEMOTHERAPY FOR RECURRENT BRAIN-TUMORS
EAGAN, RT
CREAGAN, ET
BISEL, HF
LAYTON, DD
GROOVER, RV
HERMAN, RC
[J]. ONCOLOGY, 1981, 38 (01) : 4 - 6
[10] EDWARDS MS, 1980, CANCER TREAT REP, V64, P1179